LFCR
Income statement / Annual
Last year (2024), Lifecore Biomedical, Inc.'s total revenue was $128.26 M,
an increase of 24.20% from the previous year.
In 2024, Lifecore Biomedical, Inc.'s net income was $12.01 M.
See Lifecore Biomedical, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
05/26/2024 |
05/28/2023 |
05/29/2022 |
05/31/2021 |
05/31/2020 |
05/31/2019 |
05/31/2018 |
05/31/2017 |
05/31/2016 |
05/31/2015 |
| Operating Revenue |
$128.26 M
|
$103.27 M
|
$185.79 M
|
$544.16 M
|
$590.37 M
|
$557.56 M
|
$524.23 M
|
$532.26 M
|
$541.10 M
|
$539.26 M
|
| Cost of Revenue |
$86.41 M |
$75.98 M |
$135.23 M |
$462.69 M |
$515.38 M |
$476.56 M |
$445.89 M |
$449.07 M |
$470.14 M |
$473.85 M |
| Gross Profit |
$41.85 M |
$27.29 M |
$50.55 M |
$81.47 M |
$74.99 M |
$81.00 M |
$78.34 M |
$83.19 M |
$70.96 M |
$65.41 M |
| Gross Profit Ratio |
0.33 |
0.26 |
0.27 |
0.15 |
0.13 |
0.15 |
0.15 |
0.16 |
0.13 |
0.12 |
| Research and Development
Expenses |
$8.58 M
|
$8.24 M
|
$7.84 M
|
$10.22 M
|
$11.10 M
|
$11.47 M
|
$12.80 M
|
$9.47 M
|
$7.23 M
|
$6.99 M
|
| General & Administrative
Expenses |
$0.00
|
$43.01 M
|
$42.43 M
|
$65.26 M
|
$72.09 M
|
$62.76 M
|
$50.55 M
|
$56.31 M
|
$47.42 M
|
$0.00
|
| Selling & Marketing
Expenses |
$0.00
|
$5,100.00
|
$200,000.00
|
$100,000.00
|
$100,000.00
|
$1.30 M
|
$1.40 M
|
$1.90 M
|
$2.10 M
|
$0.00
|
| Selling, General &
Administrative Expenses |
$40.46 M
|
$43.02 M
|
$42.63 M
|
$65.36 M
|
$72.19 M
|
$64.06 M
|
$51.95 M
|
$58.21 M
|
$49.52 M
|
$39.96 M
|
| Other Expenses |
$0.00 |
-$729,000.00 |
$3.30 M |
-$12.80 M |
-$4.40 M |
$1.60 M |
$2.90 M |
-$333,000.00 |
$1.20 M |
$3.11 M |
| Operating Expenses |
$49.04 M |
$51.26 M |
$50.47 M |
$75.59 M |
$83.29 M |
$75.53 M |
$64.75 M |
$67.68 M |
$56.74 M |
$46.95 M |
| Cost And Expenses |
$135.45 M |
$127.24 M |
$185.71 M |
$538.27 M |
$598.67 M |
$552.08 M |
$510.64 M |
$516.75 M |
$526.89 M |
$520.80 M |
| Interest Income |
$0.00 |
$68,000.00 |
$81,000.00 |
$48,000.00 |
$103,000.00 |
$145,000.00 |
$211,000.00 |
$16,000.00 |
$71,000.00 |
$315,000.00 |
| Interest Expense |
$18.09 M |
$18.18 M |
$17.26 M |
$15.34 M |
$9.60 M |
$5.23 M |
$1.95 M |
$1.83 M |
$1.99 M |
$1.83 M |
| Depreciation &
Amortization |
$8.86 M
|
$10.30 M
|
$7.10 M
|
$8.61 M
|
$18.30 M
|
$14.60 M
|
$11.97 M
|
$10.68 M
|
$9.07 M
|
$7.09 M
|
| EBITDA |
$35.60 M
|
-$35.98 M
|
$1.96 M
|
$13.00 M
|
-$7.16 M
|
$23.47 M
|
$24.99 M
|
$26.68 M
|
-$7.80 M
|
$30.39 M
|
| EBITDA Ratio |
0.28 |
-0.11 |
0.11 |
0.02 |
-0.02 |
0.01 |
0.03 |
0.03 |
0.03 |
0.04 |
| Operating Income Ratio
|
0.07
|
-0.25
|
0.02
|
-0.01
|
-0.01
|
-0.01
|
0.02
|
0.03
|
-0.04
|
0.03
|
| Total Other
Income/Expenses Net |
$183,000.00
|
-$42.13 M
|
-$8.90 M
|
-$20.96 M
|
-$4.77 M
|
-$1.84 M
|
$2.81 M
|
-$493,000.00
|
$934,000.00
|
$3.01 M
|
| Income Before Tax |
$9.51 M |
-$68.70 M |
-$51.92 M |
-$40.47 M |
-$51.31 M |
$3.64 M |
$16.40 M |
$15.01 M |
-$18.85 M |
$21.47 M |
| Income Before Tax Ratio
|
0.07
|
-0.67
|
-0.28
|
-0.07
|
-0.09
|
0.01
|
0.03
|
0.03
|
-0.03
|
0.04
|
| Income Tax Expense |
$183,000.00 |
$301,000.00 |
-$5.84 M |
-$7.80 M |
-$13.12 M |
$1.52 M |
-$9.36 M |
$4.34 M |
-$7.40 M |
$7.75 M |
| Net Income |
$12.01 M |
-$102.19 M |
-$46.08 M |
-$32.67 M |
-$38.19 M |
$2.12 M |
$24.83 M |
$10.59 M |
-$11.64 M |
$13.54 M |
| Net Income Ratio |
0.09 |
-0.99 |
-0.25 |
-0.06 |
-0.06 |
0 |
0.05 |
0.02 |
-0.02 |
0.03 |
| EPS |
0.39 |
-3.41 |
-1.56 |
-1.12 |
-1.31 |
0.0748 |
0.9 |
0.39 |
-0.43 |
0.5 |
| EPS Diluted |
0.33 |
-3.41 |
-1.56 |
-1.12 |
-1.31 |
0.0742 |
0.89 |
0.38 |
-0.43 |
0.5 |
| Weighted Average Shares
Out |
$30.47 M
|
$29.96 M
|
$29.47 M
|
$29.29 M
|
$29.16 M
|
$28.36 M
|
$27.70 M
|
$27.50 M
|
$27.04 M
|
$26.99 M
|
| Weighted Average Shares
Out Diluted |
$36.66 M
|
$29.96 M
|
$29.47 M
|
$29.29 M
|
$29.16 M
|
$28.61 M
|
$27.92 M
|
$27.65 M
|
$27.15 M
|
$27.34 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
